A Ph2, Colchicine For Inflammatory Carotid Injury And Disease Evolution After Radiotherapy

StatusNot Yet Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical research study is to find out if low-dose colchicine (an anti-inflammatory drug) lowers the rate of radiation-related side effects to the carotid artery in patients who have completed radiation therapy for head and neck cancer.
Trial Details
NCT Number NCT07856719
Lead Sponsor M.D. Anderson Cancer Center
Conditions
(from sponsor)		 Head and Neck Cancer
Related terms Head and Neck Neoplasms
Enrollment 250 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov